Diagnosis

SHARE VIA E-MAIL
DOWNLOAD
PRINT

The sooner you contact your physician with your symptoms, the better your chances are to recover the initial level of functionality in terms of both your social life and your work.

It is, therefore, important to be diagnosed as early as possible. 10, 14, 15 If your disease is not treated promptly and effectively, your condition could rapidly deteriorate, which may require hospitalization. 16 Without treatment, the symptoms can also negatively affect your well-being and that of your family and loved ones. 3, 17

If you experience any of the symptoms, or you feel that your medicine is not working anymore, please contact your doctor.

How will your doctor determine what the problem is?

CEE_SCHIZO_disease_02_A

Your doctor will talk with you to find out as much as possible about your symptoms and everything you experienced. Your doctor will ask you questions about:

  • your personal and medical history;
  • the symptoms you experienced;
  • for how long have you experienced them;
  • whether and how the symptoms have changed over time;
  • have there been any triggers.

Your doctor will talk with your family or those close to you in order to understand the background and history of your condition. Other medical investigations may be required such as blood tests, X-ray or brain scans. These investigations will be performed to obtain a picture of your overall health condition and determine whether there is a physical cause for your symptoms. You may be asked to complete psychological tests in order to find out more about your personality and brain function.

It is important to know how your symptoms affect your everyday life, so your doctor or his/her assistant will ask questions about your social situation, work, activities and relationships with your family and friends.

  • References

    1. APA Clinical Guidelines. American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. 2004
    2. Falkai P et al. World J Biol Psychiatry 2005; 6: 132-191.
    3. Kendler KS et al. Arch Gen Psychiatry 1996; 53: 1022-1031.
    4. World Health Organization. The World Health Report: 2001: Mental health: new understanding, new hope.
    5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition Text Revision (DSM-IV-TR). Arlington: American Psychiatric Publishing Inc. 2000.
    6. Lieberman JA et al. J Clin Psychiatry 1996; 57(suppl 9): 5-9.
    7. Breier A et al. Am J Psychiatry 1994; 151: 20-26.
    8. Robinson DG et al. Am J Psychiatry 1999; 156: 544-549.
    9. National Institute for Clinical Excellence. National Clinical Practice Guidelines Number 82.
    10. Howard R et al. Am J Psychiatry 2000; 157: 172-178.
    11. Angermeyer MC et al. Schizophr Bull 1990; 16: 293-307.
    12. Murray RM and Fearon P. J Psychiatr Res 1999; 33: 497-499.
    13. Lang UE et al. Cell Physiol Biochem 2007; 20: 687-702.
    14. Harrigan SM et al. Psychol Med 2003; 33: 97-110.
    15. Bottlender R et al. Schizophr Res 2003; 62: 37-44.
    16. Lynn Starr h. et al: Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory analysis of the PRIDE study; Schizophr Res. 2018 Apr;194:39-46. doi: 10.1016/j.schres.2017.05.005. Epub 2017 Jun 7
    17. Awad AG et al. Pharmacoeconomics 2008; 26: 149-162.
    18. Keith SJ et al. Psychiatr Serv 2004; 55: 997-1005.
    19. Lieberman JA et al. Pharmacol Rev 2008; 60: 358-403.
    20. Tandon R et al. Psychoneuroendocrinology 2003; 28(suppl 1): 9-26.
    21. Wyatt RJ. Schizophr Bull 1991; 17: 325–351
    22. Robinson DG et al. Arch Gen Psychiatry 1999; 56: 241-247.
    23. Weiden PJ et al. Psychiatr Serv 2004; 55: 886-891.
    24. Koen L et al. Psychosomatics 2007; 48: 128-134.
    25. Novick D et al. Psychiatry Res 2010; 176: 109-113.
    26. Kozma CM et al. Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate. Current Medical Research and Opinion. 2011.27;1603-1611

show more